136 related articles for article (PubMed ID: 17956685)
1. [Aberrant immunophenotypes in 126 patients with acute leukemia].
He JJ; Li YH; Sun XJ; Wan SG; Xu J; Su L; Tian D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1032-6. PubMed ID: 17956685
[TBL] [Abstract][Full Text] [Related]
2. Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia.
Kern W; Voskova D; Schnittger S; Schoch C; Hiddemann W; Haferlach T
Hematol J; 2004; 5(5):410-8. PubMed ID: 15448667
[TBL] [Abstract][Full Text] [Related]
3. [Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis].
Liu YR; Chen SS; Chang Y; Fu JY; Zhang LP; Wang H; Li LD; Zhu HH; Liu GL; Lu DP; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):853-7. PubMed ID: 17096875
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
5. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
6. [Prognosticating relapse risk based on multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia].
Wan SG; Zhao H; Sun XJ; He JJ; Su L; Xu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):557-62. PubMed ID: 19549363
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated immunophenotypes subdivided in "categories of specificity" improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia.
Rossi G; Giambra V; Minervini MM; De Waure C; Mancinelli S; Ciavarella M; Sinisi NP; Scalzulli PR; Carella AM; Cascavilla N
Cytometry B Clin Cytom; 2020 May; 98(3):216-225. PubMed ID: 31697027
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
Liu YR; Chang Y; Fu JY; Cheng YF; Zhang LP; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):335-8. PubMed ID: 16875586
[TBL] [Abstract][Full Text] [Related]
9. [Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis].
Kern W; Haferlach T
Med Klin (Munich); 2005 Jan; 100(1):54-9. PubMed ID: 15654545
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia].
Liu YR; Zhang LP; Chang Y; Cheng YF; Fu JY; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):302-5. PubMed ID: 16875577
[TBL] [Abstract][Full Text] [Related]
11. Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.
Camburn AE; Petrasich M; Ruskova A; Chan G
Pathology; 2019 Aug; 51(5):502-506. PubMed ID: 31262563
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
[TBL] [Abstract][Full Text] [Related]
13. Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome.
Griesinger F; Pirò-Noack M; Kaib N; Falk M; Renziehausen A; Troff C; Grove D; Schnittger S; Büchner T; Ritter J; Hiddemann W; Wörmann B
Br J Haematol; 1999 Apr; 105(1):241-55. PubMed ID: 10233388
[TBL] [Abstract][Full Text] [Related]
14. Use of five-color staining improves the sensitivity of multiparameter flow cytomeric assessment of minimal residual disease in patients with acute myeloid leukemia.
Voskova D; Schnittger S; Schoch C; Haferlach T; Kern W
Leuk Lymphoma; 2007 Jan; 48(1):80-8. PubMed ID: 17325851
[TBL] [Abstract][Full Text] [Related]
15. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
Cui W; Zhang D; Cunningham MT; Tilzer L
Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
[TBL] [Abstract][Full Text] [Related]
16. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
Zelezníková T; Babusíková O
Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
[TBL] [Abstract][Full Text] [Related]
17. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
Voskova D; Schoch C; Schnittger S; Hiddemann W; Haferlach T; Kern W
Cytometry B Clin Cytom; 2004 Nov; 62(1):25-38. PubMed ID: 15468339
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients.
Jalal SD; Al-Allawi NAS; Al Doski AAS
Int J Lab Hematol; 2017 Dec; 39(6):625-632. PubMed ID: 28722319
[TBL] [Abstract][Full Text] [Related]
19. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
Xia M; Zhang H; Lu Z; Gao Y; Liao X; Li H
J Pediatr Hematol Oncol; 2016 Aug; 38(6):418-22. PubMed ID: 27438018
[TBL] [Abstract][Full Text] [Related]
20. Characterization of aberrant phenotypes in acute myeloblastic leukemia.
Macedo A; Orfão A; Vidriales MB; López-Berges MC; Valverde B; González M; Caballero MD; Ramos F; Martínez M; Fernández-Calvo J
Ann Hematol; 1995 Apr; 70(4):189-94. PubMed ID: 7748963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]